Treatment outcomes and secondary cancer incidence in young patients with hairy cell leukaemia.

about

Treatment outcomes and secondary cancer incidence in young patients with hairy cell leukaemia.

Item

http://www.wikidata.org/entity/Q38805003

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Treatment outcomes and seconda ...... nts with hairy cell leukaemia.

@en

type

Item

label

Treatment outcomes and seconda ...... nts with hairy cell leukaemia.

@en

prefLabel

Treatment outcomes and seconda ...... nts with hairy cell leukaemia.

@en

P1476

Treatment outcomes and seconda ...... nts with hairy cell leukaemia.

@en

P2093

Alan Saven

http://www.w3.org/2001/XMLSchema#string

Bartlomiej M Getta

http://www.w3.org/2001/XMLSchema#string

Jae H Park

http://www.w3.org/2001/XMLSchema#string

Kaitlin M Woo

http://www.w3.org/2001/XMLSchema#string

Kanti Rai

http://www.w3.org/2001/XMLSchema#string

Omar Abdel-Wahab

http://www.w3.org/2001/XMLSchema#string

Sean Devlin

http://www.w3.org/2001/XMLSchema#string

P2860

Melanoma and non-melanoma skin cancers in hairy cell leukaemia: a Surveillance, Epidemiology and End Results population analysis and the 30-year experience at Memorial Sloan Kettering Cancer Center

Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia

Phase 2 study of cladribine followed by rituximab in patients with hairy cell leukemia.

Long-term follow-up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis.

VH4-34+ hairy cell leukemia, a new variant with poor prognosis despite standard therapy.

RAS mutations in cutaneous squamous-cell carcinomas in patients treated with BRAF inhibitors.

High prevalence of MAP2K1 mutations in variant and IGHV4-34-expressing hairy-cell leukemias.

Second cancer risk in hairy cell leukemia: analysis of 350 patients.

Recurrent CDKN1B (p27) mutations in hairy cell leukemia.

Clinical characteristics and long-term outcome of young hairy cell leukemia patients treated with cladribine: a single-institution series.

P304

402-409

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BJH.14207

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

175

http://www.w3.org/2001/XMLSchema#string

P50

Martin S Tallman

P577

2016-06-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27351754

http://www.w3.org/2001/XMLSchema#string

P921

leukemia

P932

5539949

http://www.w3.org/2001/XMLSchema#string